07:00 , Apr 24, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Smallpox Type I interferon binding protein (type I IFN bp) A study in mice suggests that targeting type I IFN...
08:00 , Dec 4, 2006 |  BC Week In Review  |  Clinical News

AFG, Viragen preclinical data

Multiferon protected rabbits from rabbitpox virus (RPV) infection when used alone or in combination with an undisclosed vaccine. The combination was more effective at alleviating symptoms including reducing the weight loss and fever. Multiferon is...
07:00 , Aug 8, 2005 |  BioCentury  |  Product Development

Corporate Profile

IntegraGen S.A. Evry, France Technology: GenomeHIP (Genome Hybrid Identity Profiling) Disease focus: Endocrine, neurology Clinical status: Market Founded: 2000 by Joerg Hager, Philippe Gesnouin, Peter Brooks, Anne Philippi, Nathalie Vionnet University collaborators: Hopital Hotel-Dieu; Hopital...
07:00 , Jul 25, 2005 |  BC Week In Review  |  Company News

Omnia Biologics Inc., AFG deal

Omnia will provide biodefense vaccine developer AFG with manufacturing and product development services. Omnia Biologics Inc. , Rockville, Md.   AFG Biosolutions Inc. , Germantown, Md.   Business: Supply/Service  ...